SEC Form 4 · accession 0000898432-18-000888
IRADIMED CORP · IRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brent Johnson
Officer — Exec. VP Sales and Marketing
Period of report
Aug 2, 2018
Accepted (ET)
Aug 3, 2018 · 5:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001325618
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 2, 2018 | A | 93,043 | $0.93 | A | 94,411 | D | |
| Common StockF1 | Aug 2, 2018 | S | 93,043 | $23.9958 | D | 1,368 | D | |
| Common Stock | Aug 3, 2018 | A | 6,957 | $0.93 | A | 8,325 | D | |
| Common StockF2 | Aug 3, 2018 | S | 6,957 | $24.1975 | D | 1,368 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $0.93 | Aug 2, 2018 | M | 93,043 | D | — | Dec 27, 2021 | Common Stock | 93,043 | 339,732 | D |
| Stock Option (Right to Buy)F4 | $0.93 | Aug 3, 2018 | M | 6,957 | D | — | Dec 27, 2021 | Common Stock | 6,957 | 332,775 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $23.90 to $24.325. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2This transaction was executed in multiple trades at prices ranging from $24.10 to $24.225. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.
- F4This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.